Search

Indijska nujna odobritev cepiv Covaxin in AstraZeneca - nejasen jezik in "pomanjkanje preglednosti"!

India’s emergency approval of Covaxin & AstraZeneca vaccines used vague language & ‘lacked transparency’


Indijska odobritev za uporabo izrednih razmerah za britansko-švedsko cepivo AstraZeneca in lokalno razvito cepivo Covaxin ni imela preglednosti in je uporabila "nejasna" besedila, je za RT povedalo več zdravstvenih strokovnjakov.


Indijski regulator je v nedeljo opozoril na "omejeno" uporabo dveh cepiv v izrednih primerih: Covaxin, ki ga je razvilo podjetje Bharat Biotech s sedežem v Hyderabadu, in cepivo AstraZeneca / Oxford, ki ga lokalno proizvaja indijski serumski inštitut in ga promovira pod imenom Covishield. Indijski glavni nadzornik za zdravila V.G. Somani je vztrajal, da sta obe cepivi "110-odstotno varni" in povzročata le blage simptome, ki so skupni vsem cepivom.


Skupina zdravstvenih nadzornikov, All India Drug Action Network (AIDAN), je protestirala proti tej potezi in vlado pozvala, naj zagotovi "podrobne utemeljitve" za odločitev in dodatne podatke o varnosti in učinkovitosti cepiva.





India’s emergency-use approval for the British-Swedish AstraZeneca vaccine and the country’s locally developed jab, Covaxin, was lacking in transparency and used “vague” wording, several healthcare experts told RT.


The Indian regulator greenlighted the “restricted” emergency use of two inoculations on Sunday: Covaxin, developed by the Hyderabad-based firm Bharat Biotech, and the AstraZeneca/Oxford vaccine, manufactured locally by the Serum Institute of India and promoted under the name Covishield. India’s chief drug control officer V.G. Somani insisted both jabs are “110 percent safe” and produced only mild symptoms that are common to all vaccines.


A health watchdog group, the All India Drug Action Network (AIDAN), has protested the move, calling on the government to provide a “detailed rationale” for the decision and additional data on the shot’s safety and efficacy.


Vir: RTnews

https://www.rt.com/news/511633-india-vaccine-transparency-vague/

18 views0 comments